Home › Therapeutic areas › Immunology › Sjögren's Syndrome

Sjögren's Syndrome (6 companies)

Companies with an active program in Sjögren's Syndrome.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ALMS Alumis DermatologyImmunology+1 1 Phase 3 $628M 5
CGEM Cullinan Therapeutics HematologyImmunology+2 Rare 1 NDA Submitted $602M 10
MGTX MeiraGTx ImmunologyMetabolic+2 Rare 1 Phase 3 $827M 16
GLUE Monte Rosa Therapeutics CardiovascularDermatology+3 Rare 1 Phase 2 $775M 7
VOR Vor Biopharma ImmunologyNeurology Rare 1 Phase 3 $1.12B 2
XNCR Xencor ImmunologyNeurology+1 Rare 1 Approved $2.59B 28